Welcome to our dedicated page for Atlassian SEC filings (Ticker: TEAM), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Atlassian's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Atlassian's regulatory disclosures and financial reporting.
TEAM: A Form 144 notice reports a proposed sale of 982 shares of Common Stock by Brian Duffy, dated 02/17/2026. The filing lists a value of $80,327.40 tied to that transaction.
The broker-dealer shown is Morgan Stanley Smith Barney LLC Executive Financial Services at 1 New York Plaza. The securities type is listed as Restricted Stock with a related date of 02/18/2026.
Morgan Stanley Smith Barney LLC submitted a Form 144 reporting a proposed sale of 3,072 restricted common shares (planned for 02/18/2026) and disclosing a sale of 4,009 common shares by Rajeev Rajan on 02/17/2026 for $327,935.40.
The filing lists the securities as restricted stock for the 3,072-share item and identifies the broker address and exchange (NASDAQ); timing and settlement details beyond the dates shown are not provided in the excerpt.
TEAM lists the proposed sale of 1,653 shares of restricted common stock to be sold on 02/18/2026. The filing also reports a prior sale by Joseph Binz of 2,949 common shares on 02/17/2026 for $241,227.61.
Atlassian Corporation appointed James Chuong as Chief Financial Officer, effective March 30, 2026, and he will serve as the company’s principal financial officer from that date. Chuong has been Chief Financial Officer at LinkedIn, a subsidiary of Microsoft, since July 2021 and has held multiple senior finance roles there since 2013.
His compensation package includes a $600,000 annual base salary, a target annual bonus equal to 75% of base salary, and an initial restricted stock unit grant with a target value of $22 million vesting quarterly over four years. He will also receive a one-time $2 million signing bonus, subject to repayment if he resigns within twelve months, and will be eligible for severance and change-in-control benefits under Atlassian’s executive severance plan, plus the company’s standard indemnification agreement.
Atlassian Corp’s Chief Accounting Officer Gene Liu reported selling 908 shares of Class A common stock on February 17, 2026 in open-market transactions. A footnote explains these sales were made solely to cover tax withholding obligations tied to vesting and settlement of RSUs, and were not discretionary.
Sale prices were in the low-to-mid $80s per share, based on ranges disclosed in the footnotes. After these transactions, Liu directly holds 60,420 Class A shares and has an additional 120 shares held indirectly by his spouse.
Atlassian Corp Chief Revenue Officer Brian Duffy reported automated share sales tied to tax withholding. On February 17, 2026, he sold an aggregate of 982 shares of Atlassian Class A Common Stock in a series of open-market transactions at prices generally in the low-to-mid $80 range.
The footnotes explain these sales were executed under a “sell to cover” arrangement to pay tax obligations arising from the vesting and settlement of restricted stock units and did not represent discretionary trading decisions. After these sales, Duffy directly held 125,554 shares of Atlassian Class A Common Stock.
Atlassian Corp Chief Technology Officer Rajeev Bashyam reported selling 4,009 shares of Class A Common Stock on February 17, 2026. The sales were executed in multiple open-market transactions and, according to the filing, were made solely to cover tax withholding obligations tied to the vesting and settlement of restricted stock units (RSUs), rather than as discretionary trades.
After these tax-related sales, Bashyam directly holds 215,988 Atlassian Class A shares.
Atlassian Corp’s Chief Financial Officer Joseph Leo Binz reported automatic insider sales of Class A Common Stock. On February 17, 2026, he sold a total of 2,949 shares in several open-market transactions at prices ranging from about $80.42 to $86.73. According to the disclosure, these sales were made solely to cover tax withholding obligations tied to the vesting and settlement of restricted stock units under a “sell to cover” arrangement, and were not discretionary trades. After these transactions, Binz continued to own 210,292 shares directly.
A shareholder in TEAM has filed a Rule 144 notice to sell 982 shares of common stock through Morgan Stanley Smith Barney, with an aggregate market value of $80,327.40. The planned sale date is listed as 02/17/2026 on the NASDAQ exchange.
The filing notes that these 982 shares were acquired as restricted stock from the issuer on 02/13/2026. As context, common shares outstanding are shown as 169,610,457. Over the past three months, Brian Duffy sold 1,940 shares of common stock for gross proceeds of $286,078.03.
An insider plans to sell up to 2,949 shares of common stock under Rule 144 through Morgan Stanley Smith Barney LLC on or about 02/17/2026, to be traded on NASDAQ. The aggregate market value of the planned sale is $241,227.61, compared with 169,610,457 shares outstanding.
The shares were acquired as restricted stock from the issuer on 02/13/2026. The filer also reported a prior sale of 1,710 common shares on 11/19/2025 for $252,161.56. By signing, the seller represents they do not know any undisclosed material adverse information about the issuer.